Chemotherapy-Free Treatment Shows Promise for Some Metastatic Breast Cancer Patients
In a small new study, a chemo-free regimen of four targeted therapies benefited 97% of women with HR-positive, HER2-positive metastatic breast cancer.
Health News is provided as a service to Nipomo Rexall Drug site users by HealthDay. Nipomo Rexall Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.